Mycor Capital Management, LLC (hereinafter “Mycor”, “we”, “us”, “our” or the “Firm”) is
organized as a Delaware limited liability company with its principal place of business in
Stamford, Connecticut. Mycor is principally owned and controlled by Daniel Allen, Jack Franke,
Matt Knopman and Joshua Samuelson (the “Founding Partners”).
We serve as the investment adviser, with discretionary trading authority, to private, pooled
investment vehicles, the securities of which are offered through a private placement
memorandum to accredited investors, as defined under the Securities Act of 1933, as
amended, and qualified purchasers, as defined under the Investment Company Act of 1940,
as amended. We do not tailor our advisory services to the individual needs of any particular
investor.
Mycor manages the following private, pooled investment vehicles:
• Mycor All-Weather Credit Offshore Fund, Ltd, a Cayman Islands exempted company
(the “All-Weather Offshore Fund”);
• Mycor All-Weather Credit Onshore Fund, LP, a Delaware limited partnership (the “All-
Weather Onshore Fund”);
• Mycor All-Weather Credit Master Fund, LP, a Cayman Islands exempted limited
partnership (the “All-Weather Master Fund”);
• Mycor Liquid Credit Onshore Fund, LP, a Delaware limited partnership (the “Liquid
Credit Onshore Fund”); and
• Mycor Liquid Credit Master Fund, LP, a Cayman Islands exempted limited partnership
(the “Liquid Credit Master Fund”).
Each of the above mentioned pooled investment vehicles are herein each referred to as a
“Fund” or “Client”, and collectively referred to as the “Funds” or the “Clients”.
The Onshore Funds’ “Limited Partners” and the Offshore Funds’ “Shareholders” are hereafter
collectively referred to as the “Investors” where appropriate.
Our investment decisions and advice with respect to the Funds are subject to each Fund’s
investment objectives and guidelines, as set forth in its respective “Offering Documents.”
We do not currently participate in any Wrap Fee Programs.
As of December 31, 2023, the Investment Manager has regulatory assets under management
of $354,220,094, all of which is managed on a discretionary basis.